- Home
- VTS vs AVTX Comparison
VTS vs AVTX Comparison
Compare VTS & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VTS | AVTX |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 733.0M | 710.1M |
| IPO Year | 2022 | 2015 |
Fundamental Metrics
Financial Performance| Metric | VTS | AVTX |
|---|---|---|
| Price | $17.97 | $12.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 14 |
| Target Price | $21.50 | ★ $44.08 |
| AVG Volume (30 Days) | 375.2K | ★ 1.0M |
| Earning Date | 11-02-2026 | 11-05-2026 |
| Dividend Yield | ★ 9.77% | N/A |
| EPS Growth | N/A | ★ 72.07 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $273,989,000.00 | $27,813,137.00 |
| Revenue This Year | $26.85 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 13.22 | ★ 2312.27 |
| 52 Week Low | $15.00 | $11.21 |
| 52 Week High | $22.91 | $24.27 |
Technical Indicators
Market Signals| Indicator | VTS | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 59.31 | 33.71 |
| Support Level | $17.33 | N/A |
| Resistance Level | $18.61 | $20.54 |
| Average True Range (ATR) | 0.38 | 0.83 |
| MACD | 0.11 | -0.02 |
| Stochastic Oscillator | 69.52 | 27.45 |
Price Performance
Historical ComparisonAbout VTS Vitesse Energy Inc.
Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana with limited operations. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.